Liu et al. [36] found that CASR agonists significantly up-regulated the expression of hyaluronan synthase 2 (HAS2) in porcine cumulus cells, while CASR inhibitors down-regulated all HAS2, prostaglandin-endoperoxide synthase 2 (PTGS2) and tumor necrosis. The gene discussed is CASR; the disease is neoplasm.